Yufan Stephanie Wang sold $66k of PRGS
Chief Legal Officer at PROGRESS SOFTWARE CORP /MA. 1,428 shares at an average of $46.26, traded Oct 3, 2025, filed Oct 3, 2025.
Score components
- +15RoleOfficer
- +8Trade size$66k at market
- +20Share of holdings soldSold 68% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000876167-25-000171, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 1, 2025 | MOption exercise Common Stock10b5-1 | +460 | $0.00 | $0 | 460 | Oct 3, 2025 |
| Oct 1, 2025 | FTax withholding Common Stock10b5-1 | -204 | $44.21 | $9,019 | 256 | Oct 3, 2025 |
| Oct 1, 2025 | MOption exercise Common Stock10b5-1 | +1,070 | $0.00 | $0 | 1,326 | Oct 3, 2025 |
| Oct 1, 2025 | FTax withholding Common Stock10b5-1 | -475 | $44.21 | $21k | 851 | Oct 3, 2025 |
| Oct 1, 2025 | MOption exercise Common Stock10b5-1 | +1,038 | $0.00 | $0 | 1,889 | Oct 3, 2025 |
| Oct 1, 2025 | FTax withholding Common Stock10b5-1 | -461 | $44.21 | $20k | 1,428 | Oct 3, 2025 |
| Oct 1, 2025 | MOption exercise Common Stock10b5-1 | +1,201 | $0.00 | $0 | 2,629 | Oct 3, 2025 |
| Oct 1, 2025 | FTax withholding Common Stock10b5-1 | -533 | $44.21 | $24k | 2,096 | Oct 3, 2025 |
| Oct 3, 2025 | SOpen-market sale Common Stock10b5-1 | -1,428 | $46.26 | $66k | 668 | Oct 3, 2025 |
| Oct 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -460 | $0.00 | $0 | 0 | Oct 3, 2025 |
| Oct 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -1,070 | $0.00 | $0 | 1,070 | Oct 3, 2025 |
| Oct 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -1,038 | $0.00 | $0 | 3,114 | Oct 3, 2025 |
| Oct 1, 2025 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -1,201 | $0.00 | $0 | 6,006 | Oct 3, 2025 |
Related signals
Other insiders at PROGRESS SOFTWARE CORP /MA and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 11Weak | PROGRESS SOFTWARE CORP /MA | Yufan Stephanie Wang Chief Legal Officer | $46k 1,245 shares | -26% | |
| 5Weak | PROGRESS SOFTWARE CORP /MA | Anthony Folger Chief Financial Officer | $240k 6,000 shares | -11% | |
| 10Weak | PROGRESS SOFTWARE CORP /MA | Ian Pitt Chief Information Officer | $19k 409 shares | -5% | |
| 20Weak | PROGRESS SOFTWARE CORP /MA | Anthony Folger Chief Financial Officer | $254k 5,474 shares | -11% | |
| 41Moderate | PRGSbuy PROGRESS SOFTWARE CORP /MA | Rainer Gawlick director | $74k 1,710 shares | +3% | |
| 52Moderate | PROGRESS SOFTWARE CORP /MA | Yogesh K Gupta Chief Executive Officer | $103k 2,100 shares | +1% | |
| 53Moderate | PROGRESS SOFTWARE CORP /MA | David Krall director | $251k 5,125 shares | +5% | |
| 36Weak | PROGRESS SOFTWARE CORP /MA | Anthony Folger Chief Financial Officer | $293k 5,529 shares | -11% | |
| 15Weak | PROGRESS SOFTWARE CORP /MA | Sundar Subramanian EVP/GM Infrastructure Mgmt | $30k 501 shares | -2% | |
| 31Weak | PROGRESS SOFTWARE CORP /MA | Ian Pitt Chief Information Officer | $143k 2,186 shares | -25% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.